GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dishman Carbogen Amics Ltd (NSE:DCAL) » Definitions » EBITDA Margin %

Dishman Carbogen Amics (NSE:DCAL) EBITDA Margin % : 7.24% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Dishman Carbogen Amics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dishman Carbogen Amics's EBITDA for the three months ended in Dec. 2023 was ₹472 Mil. Dishman Carbogen Amics's Revenue for the three months ended in Dec. 2023 was ₹6,511 Mil. Therefore, Dishman Carbogen Amics's EBITDA margin for the quarter that ended in Dec. 2023 was 7.24%.


Dishman Carbogen Amics EBITDA Margin % Historical Data

The historical data trend for Dishman Carbogen Amics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dishman Carbogen Amics EBITDA Margin % Chart

Dishman Carbogen Amics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.72 25.69 14.75 16.00 12.45

Dishman Carbogen Amics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.42 0.21 17.75 11.30 7.24

Competitive Comparison of Dishman Carbogen Amics's EBITDA Margin %

For the Biotechnology subindustry, Dishman Carbogen Amics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's EBITDA Margin % falls into.



Dishman Carbogen Amics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dishman Carbogen Amics's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=3005.2/24129.2
=12.45 %

Dishman Carbogen Amics's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=471.6/6510.9
=7.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dishman Carbogen Amics  (NSE:DCAL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Dishman Carbogen Amics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dishman Carbogen Amics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dishman Carbogen Amics (NSE:DCAL) Business Description

Traded in Other Exchanges
Address
Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.

Dishman Carbogen Amics (NSE:DCAL) Headlines

No Headlines